HOSPICES CIVILS DE LYON
🇫🇷France
Renal Magnetic Resonance (MR) Elastography in Healthy Volunteers
Not Applicable
Completed
- Conditions
- Healthy
- First Posted Date
- 2009-04-07
- Last Posted Date
- 2019-05-28
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 10
- Registration Number
- NCT00876629
- Locations
- 🇫🇷
Department of Urinary an Vascular Radiology, Hôpital E. Herriot, Lyon, France
Efficacy of Minoxidil in Children With Williams-Beuren Syndrome
- First Posted Date
- 2009-04-06
- Last Posted Date
- 2019-07-26
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 21
- Registration Number
- NCT00876200
- Locations
- 🇫🇷
Service de Cardiologie - Hôpital des Enfants, Toulouse, France
🇫🇷Service de Cardiologie Infantile, CHU Nancy, Nancy, France
🇫🇷Service de Cardiologie Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer
Phase 3
Completed
- Conditions
- Liver Cancer
- Interventions
- Radiation: iodine I 131 ethiodized oil
- First Posted Date
- 2009-03-27
- Last Posted Date
- 2011-08-16
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 120
- Registration Number
- NCT00870558
- Locations
- 🇫🇷
Hopital Edouard Herriot - Lyon, Lyon, France
Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton Spectroscopy
Not Applicable
Completed
- Conditions
- LesionsMultiple Sclerosis
- Interventions
- Procedure: 3T MR scanner
- First Posted Date
- 2009-03-13
- Last Posted Date
- 2013-06-21
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 6
- Registration Number
- NCT00861172
- Locations
- 🇫🇷
Services de Neurologie A et Service de Neuroradiologie, Pôle transversal d'imagerie, Hôpital Neurologique, BRON Cedex, France
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer
Phase 3
Completed
- Conditions
- MenopauseOsteopeniaBreast Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-03-11
- Last Posted Date
- 2013-10-31
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 20
- Registration Number
- NCT00859703
- Locations
- 🇫🇷
Service de Rhumatology et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France
MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction
Completed
- Conditions
- Myocardial Infarction
- Interventions
- Genetic: Blood sample
- First Posted Date
- 2009-03-11
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 1011
- Registration Number
- NCT00859300
- Locations
- 🇫🇷
Hôpital cardiologique, Lyon, France
Study Evaluating the Effectiveness of the Use of Prosthesis With Trans-Obturator Way for the Correction of Anterior Prolapse
Not Applicable
Completed
- Conditions
- Anterior Prolapse
- Interventions
- Procedure: Traditional surgeryDevice: Perigee® prosthesis
- First Posted Date
- 2009-03-11
- Last Posted Date
- 2019-05-28
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 78
- Registration Number
- NCT00859417
- Locations
- 🇫🇷
Hôpital femme Mère Enfant, Bron, France
Arnogene: A Phosphocalcic Study in Dialysis
Completed
- Conditions
- Dialysis
- Interventions
- Genetic: blood sample
- First Posted Date
- 2009-03-09
- Last Posted Date
- 2009-09-04
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 1200
- Registration Number
- NCT00858260
- Locations
- 🇫🇷
Hôpital Edouard Herriot, Lyon, France
Validation of the Quark RMR Calorimeter (Cosmed) Versus Deltatrac II (GE Health Care Clinical Systems)
Not Applicable
- Conditions
- HealthyObesity
- Interventions
- Device: Quark RMRDevice: Deltatrac II
- First Posted Date
- 2009-02-20
- Last Posted Date
- 2009-08-19
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 30
- Registration Number
- NCT00848471
- Locations
- 🇫🇷
Centre de Recherche en Nutrition Rhône Alpes, Hôpital Edouard Herriot, Lyon, Rhone-Alps, France
Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study
- First Posted Date
- 2009-02-13
- Last Posted Date
- 2013-05-30
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 25
- Registration Number
- NCT00843440
- Locations
- 🇫🇷
Hospices Civils de Lyon, Lyon, France
© Copyright 2025. All Rights Reserved by MedPath